chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary thrombosis
Clinical narrative: got blood clots in his lung; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PULMONARY THROMBOSIS (medically significant), outcome "unknown", described as "got blood clots in his lung". Therapeutic measures were taken as a result of pulmonary thrombosis. Clinical course: Reporter's husband got his last shot and got blood clots in his lung. He had to take medication so he wouldn't get clots.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Still have pain in my arm at the point where the vaccine was given; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from License Party. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), in 2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 2021, for COVID-19 immunization, reaction(s): "Vaccination site pain". The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Still have pain in my arm at the point where the vaccine was given". The event "still have pain in my arm at the point where the vaccine was given" required physician office visit.  Additional information: The patient was vaccinated two doses in 2021. She still had pain in her arm at the point where the vaccine was given. When she went to the doctor, they did not know why and there was no solution.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: After the second booster I got Covid; After the second booster I got Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "After the second booster I got Covid". Clinical Course: Just to let them know, all of patient's vaccines were Pfizer two Covid and three boosters.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300220100 same reporter/patient, different dose/event;US-PFIZER INC-202300220101 same reporter/patient, different dose/event;
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: Drug ineffective; We both came down with Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 15May2023, outcome "unknown", described as "Drug ineffective "; SUSPECTED COVID-19 (medically significant) with onset 15May2023, outcome "unknown", described as "We both came down with Covid". Clinical course: Patient's husband and patient have had all our vaccines and boosters except the last one out now. They both came down with Covid, 15May2023. It was mild-4 days and no worse the a cold or bad allergies. Patient asked when should they take this last booster available now.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300220253 same patient/product, different dose/event;
Age: 0.08
Sex: F
Vaccine: UNK
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: expired pentacel was administered with no reported adverse event; Initial information received on 12-Jun-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (Caregiver).  This case involves a 32 days old female patient for whom  expired Diphtheria/Tetanus/5 Hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (Vero)] was administered with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received expired dose of 0.5 ml dose 1 of suspect Diphtheria/Tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine suspension for injection with unknown strength, batch number & expiry date via unknown route in unknown administration site for Immunization with no reported adverse event (expired product administered) (latency: same day).  Information on the batch number was requested.  Action taken: not applicable.  At time of reporting, the outcome was Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 18.0
Sex: F
Vaccine: MEN
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: pregnant received menquadfi with no reported adverse event; Initial information received on 12-Jun-2023 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 18 years old female patient who was exposed to vaccine meningococcal A-C-Y-W135 (T conj) vaccine [Menquadfi] in context of pregnant with no reported adverse event. Data regarding this pregnancy were received prospectively.  The date of last menstrual period was Jan-2023. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 12-Jun-2023, the pregnant patient received 0.5 mL dose 1 of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine (batch number:  U7616AC; expiry date: 11-Apr-2025) via intramuscular route in left deltoid for Immunization with no reported adverse event (exposure during pregnancy) (same day latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event pregnant received menquadfi with no reported adverse event. Additionally, at time of reporting, the outcome of the pregnancy is unknown.
Age: 23.0
Sex: F
Vaccine: RAB
Symptoms: Medication error, No adverse event, Product administered at inappropriate site
Clinical narrative: patient received imovax intramuscularly into their gluteal area/doses were administered to the incorrect location and need to be re-administered with no reported adverse event; Initial information received on 12-Jun-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 23 years old female patient who received RABIES (HDC) VACCINE [IMOVAX RABIES] intramuscularly into their gluteal area/doses were administered to the incorrect location and need to be re-administered with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 05-Jun-2023, the patient received an unknown dose (dose 1) once of suspect RABIES (HDC) VACCINE (Powder and solvent for suspension for injection) (lot: V1B591M; expiry date: 10-May-2024) via intramuscular route in left gluteal region for immunization. On 09-Jun-2023 she also received a dose 2 of the same vaccine (lot: V1B591M; expiry date: 10-May-2024) via intramuscular route in right gluteal region for immunization.  On 05-Jun-2023 the patient received imovax rabies vaccine intramuscularly into their gluteal area/doses were administered to the incorrect location and need to be re-administered with no reported adverse event (product administered at inappropriate site) (latency: same day).  It was reported, "Caller noted that the patient/patient's family realized the incorrect positioning for administration. Caller had further questions about when to restart the rabies vaccine series. Do they need to wait until the next scheduled date or should they start it sooner? The next scheduled date in the series would be 16JUN2023. Caller would like to know how to proceed and whether they could start the revaccination series earlier? Caller requested any additional information available in regards to when the series should be restarted as there was limited information available in this document."   Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 3.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Medication error, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 3-year-old pediatric patient who received a dose of QUADRACEL intended for children aged 4-6 years with no reported adverse event; Initial information received on 13-Jun-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 3 years old pediatric male patient who received a dose of Diphtheria-15/Tetanus/5 Hybrid AC Pertussis/IPV (MRC5) vaccine [Quadracel] intended for children aged 4-6 years with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant (s) and family history were not provided.   On 07-Jun-2023, the patient of age 3 years received a dose of 0.5 ml (1x) dose 4 of suspect Diphtheria-15/Tetanus/5 Hybrid AC pertussis/IPV (MRC5) vaccine suspension for injection (lot: U7526AA, Expiry date: 07-Sep-2024) via intramuscular route in unknown administration site for immunization which was intended for children aged 4-6 years with no reported adverse event (product administered to patient of inappropriate age) (latency: same day).  Action taken: not applicable.  At time of reporting, the outcome was Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.75
Sex: M
Vaccine: HIBV
Symptoms: Expired product administered
Clinical narrative: an expired Act-Hib inadvertently administered to an 9-month-old consumer with no reported adverse event; Initial information received on 13-Jun-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 9 months old male patient who was administered an expired HIB (PRP/T) vaccine [ACT-HIB] inadvertently with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 25-May-2023, the patient received an expired dose 2 of suspect HIB (PRP/T) vaccine, powder and solvent for solution for injection (batch number: UJ665AAA; expiry date: 11-Mar-2023) via unknown route in unknown administration site for prophylactic vaccination (immunization), inadvertently with no reported adverse event (expired product administered) (same day latency).  Action: not applicable.  At time of reporting, the outcome was Unknown for the event an expired act-hib inadvertently administered to an 9-month-old consumer with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 49.0
Sex: F
Vaccine: ANTH
Symptoms: Ageusia, Diarrhoea, Headache, Nausea, Neck pain
Clinical narrative: Tingling and sore throat, headache, left sided tongue nimbleness and loss of taste, nausea/diarrhea, neck pain
Age: 49.0
Sex: F
Vaccine: ANTH
Symptoms: Oropharyngeal pain, Paraesthesia, Tongue disorder
Clinical narrative: Tingling and sore throat, headache, left sided tongue nimbleness and loss of taste, nausea/diarrhea, neck pain
Sex: U
Vaccine: PPV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE/no PQC; Product experienced a temperature excursion and was administered before they were aware of TE; This spontaneous report has been received from a medical assistant and refers to a patient of unknown age and gender   The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported.  On 05-JUN-2023, the patient was vaccinated with a pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection that had experienced a temperature excursion (product storage error) (lot number W027449 has been determined to be valid for pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23); expiration date has been established as 25-SEP-2024) administered for prophylaxis (strength, and route of administration were not provided). No additional adverse events were reported, the patient had not experienced any signs or symptoms of adverse events.  This is one of 2 reports from the same reporter. ; Sender's Comments:  US-009507513-2306USA004149:
Sex: U
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Arthralgia, Lymphadenopathy, Nausea, Pyrexia
Clinical narrative: Joint pain; I got 3 days ago. nausea; I got 3 days ago.upset stomach; I got 3 days ago. fever (101 F); swollen lymph under arm where I got the shot; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of joint pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of no adverse event (1st dose received on unknown date).   In JUN-2023, the patient received the 2nd dose of Shingles vaccine (unknown arm). In JUN-2023, less than a week after receiving Shingles vaccine, the patient experienced joint pain (Verbatim: Joint pain), nausea (Verbatim: I got 3 days ago. nausea), upset stomach (Verbatim: I got 3 days ago.upset stomach), fever (Verbatim: I got 3 days ago. fever (101 F)) and swollen lymph nodes (Verbatim: swollen lymph under arm where I got the shot). The outcome of the joint pain, nausea, upset stomach and fever were resolved and the outcome of the swollen lymph nodes was not resolved.   It was unknown if the reporter considered the joint pain, nausea, upset stomach, fever and swollen lymph nodes to be related to Shingles vaccine.     It was unknown if the company considered the joint pain, nausea, upset stomach, fever and swollen lymph nodes to be related to Shingles vaccine.   Additional Information: GSK receipt date: 10-JUN-2023 This case was reported by a patient via interactive digital media. The patient had no side effects from the 1st shot but did with the 2nd shot which she/he got 3 days ago the reporting day. She/he had Joint pain, nausea, upset stomach, fever (101 F), and swollen lymph node under arm where he/she got the shot.  Lymph node was still swollen but other side effects had gone. Everything was tolerable but the patient was glad that there was not a 3rd shot. The follow-up could not be possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Rash vesicular, Vaccine positive rechallenge
Clinical narrative: ache; rash that looked like chickenpox; This non-serious case was reported by a nurse via sales rep and described the occurrence of pain in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (received 1st dose on an unknown date, refer case US2023AMR083356.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: ache) and varicella-like rash (Verbatim: rash that looked like chickenpox). The patient was treated with acyclovir. Rechallenge with Shingrix was positive. The outcome of the pain and varicella-like rash were not reported.   It was unknown if the reporter considered the pain and varicella-like rash to be related to Shingrix.     It was unknown if the company considered the pain and varicella-like rash to be related to Shingrix.   Linked case(s) involving the same patient:  US2023AMR083356   Additional Information: GSK Receipt date: 13-JUN-2023 The patient age was mid-70. The reporter did not consent to follow up.; Sender's Comments:  US-GSK-US2023AMR083356:same patient same reporter
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Cold urticaria, Exposure to extreme temperature, Vision blurred
Clinical narrative: Cold urticaria, induced within 5 minutes of cold exposure. Resolves after two hours.  Intermittent unilateral vision blurriness, resolves after 15 minutes.
Age: 0.08
Sex: F
Vaccine: HEPA
Symptoms: Wrong product administered
Clinical narrative: Pt was administered the wrong vaccine. She was supposed to have been given a Hep B vaccine and she was given a Hep A in error. The provider she was seeing ordered the correct vaccine.  The CMA grabbed the wrong vaccine out of the vaccine refrigerator.
Age: 57.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reactions reported when Patient was advised of outdated vaccine.
Age: 32.0
Sex: M
Vaccine: UNK
Symptoms: Epstein-Barr virus infection reactivation, Laboratory test abnormal, Small fibre neuropathy
Clinical narrative: Small fiber neuropathy measured by a sudoscan and a corneal confocal microscopy and a reactivation of the epstein barr virus
Age: 22.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reactions reported when Patient was advised of outdated vaccine.
Age: 40.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reactions reported when Patient was advised of outdated vaccine.
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reactions reported when Patient was advised of outdated vaccine.
Age: 64.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reactions reported when Patient was advised of outdated vaccine.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reactions reported when Patient was advised of outdated vaccine.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reactions reported when Patient was advised of outdated vaccine.
Age: 50.0
Sex: F
Vaccine: MMR, MMRV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient here for immunizations. Patient requested #2 MMR & #2 varicella. The #2 MMR planted in L Sq Arm. The varicella was inadvertently chosen with a Proquad SQ RA. Pt notified. No signs or symptoms pf adverse reactions at this time. Conversation occurred with interpreter.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ischaemic stroke
Clinical narrative: ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cerebrovascular accident
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: LT THIGH BECAME RED, SWOLLEN AND WARM TO TOUCH ON 6/13/23 . PATIENT WAS SEEN IN OUR OFFICE ON 6/14/23.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Tendonitis
Clinical narrative: I did not have an adverse reaction to the vaccine.  I was having trouble with my left ankle, and I made an appointment with my doctor. I was diagnosed with acute tendonitis in my left ankle. As of now, I have to have surgery in July.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Polyneuropathy
Clinical narrative: DRUG INDUCED POLYNEUROPATHY
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA
Age: 53.0
Sex: M
Vaccine: COVID19-2
Symptoms: Myocardial ischaemia, Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA  DEMAND ISCHEMIA
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiogenic shock, Hypotension, Symptom recurrence
Clinical narrative: TRANSIENT HYPOTENSION CARDIOGENIC SHOCK 12/20/2022,  12/15/2022,  1/13/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 45.0
Sex: M
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 11/2/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 36.0
Sex: F
Vaccine: HEP
Symptoms: Eye pain, Headache, Nausea, Peripheral swelling, Rash
Clinical narrative: The patient was instructed to wait for 15 minutes and the patient started to have a headache with eye pain, swelling in hands, nausea, the systemic rash.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Hypotension, Obstructive sleep apnoea syndrome
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA HYPOTENSION CHRONIC RESPIRATORY FAILURE
Age: 23.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site rash, Pruritus
Clinical narrative: RASH AT INJECTION SITE, DOWN LEFT FOREARM STEROID INJECTION TO HELP WITH RASH AND ITCHING
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Pain
Clinical narrative: tightness, pressure and dull pain in left chest (small area over heart) - fluctuates over time - not constant, has not gone away after almost a year
Age: 16.0
Sex: M
Vaccine: HPV9
Symptoms: Bradycardia, Decerebrate posture, Full blood count, Hypotension, Loss of consciousness
Clinical narrative: A syncopal episode with decerebrate posturing, hypotension and bradycardia. Spontaneous and immediate return of consciousness with approx 30 minutes until complete recovery and the patient was able to ambulate out of the clinic
Age: 16.0
Sex: M
Vaccine: HPV9
Symptoms: Metabolic function test, Syncope
Clinical narrative: A syncopal episode with decerebrate posturing, hypotension and bradycardia. Spontaneous and immediate return of consciousness with approx 30 minutes until complete recovery and the patient was able to ambulate out of the clinic
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 3/23/21 lot# EP6955;  Pfizer4/13/21 Lot# EP6955;  Pfizer 10/15/21 lot# FF2590;
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine expired 6/12/23 and was given 6/13/23. No adverse reaction reports by patient.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 2/25/21 lot# 025A21A;  Moderna 3/25/21 lot# 008B21A
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines  Pfizer 1/12/21 lot# EL0142;  Pfizer 1/30/21 lot# EL9265;  Pfizer 9/2/21 lot# 30130BA;  Pfizer 9/15/22 lot# GJ5342
Age: 36.0
Sex: M
Vaccine: SMALLMNK
Symptoms: No adverse event
Clinical narrative: No adverse events, did call pt, and inform him this was his 3 dose and to see how pt is doing.  He stated that he is doing well  and has had no reaction. Will call Health Dept if any concerns, phone # provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, Dyspnoea at rest, Hyperkalaemia, Pneumonia
Clinical narrative: Patient was seen at the local ER for c/o shortness of breath at rest for the past 5 days.  Patient was previously seen by PCP and diagnosed wth covid and started on paxlovid.  Patient was admitted with a Dx of pneumonia, acute kidney failure and hyperkalemia for further evaluation and treatment.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 4/2/21 lot# 043B21A;  Moderna 12/14/21 lot# 060H21A
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 4/20/21 lot# Ew0164;  Pfizer 5/11/21 lot# EW0179
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Pfizer 1/25/21 lot# EL9261;  Pfizer 2/5/21 lot# EL9267;  Pfizer 8/27/21 lot# EW0173; Pfizer 4/16/22 lot# FJ9943
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthma, Blood test normal, Chest X-ray normal, Chest discomfort, Cough
Clinical narrative: I had a tight chest, coughing that was constant, shortness of breath I made an appointment with my doctor. I had a virtual appointment with my doctor. She ordered a chest x-ray and blood work to rule out pneumonia and infection. Everything came back normal. My doctor then prescribed Tessalon Perles for my cough, Flovent to help me breath for my asthma diagnosis and nasal spray to help keep my breathing passages open.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea
Clinical narrative: I had a tight chest, coughing that was constant, shortness of breath I made an appointment with my doctor. I had a virtual appointment with my doctor. She ordered a chest x-ray and blood work to rule out pneumonia and infection. Everything came back normal. My doctor then prescribed Tessalon Perles for my cough, Flovent to help me breath for my asthma diagnosis and nasal spray to help keep my breathing passages open.
Age: 48.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 8/14/21 Lot# 091D;  Moderna 9/11/21 lot# 052E21A;  Pfizer 1/1/23 Lot# GJ6739
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 8/17/21 lot# EW0186;  Pfizer 10/9/21 lot# 30155BA
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: False labour, Hypersensitivity, Oligohydramnios, Pregnancy, Third trimester pregnancy
Clinical narrative: ALLERGIC REACTION, INIT 10/4/2022 FALSE LABOR BEFORE 37 WEEKS, THIRD TRIMESTER ALLERGIC REACTION, INIT 10/4/2022 OLIGOHYDRAMNIOS, THIRD TRIMESTER, SINGLETON/UNSPECIFIED FETUS
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Liver function test increased
Clinical narrative: Severe headaches, elevated liver function tests
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 3/9/21 lot# 030A21A; Moderna 4/6/21 lot# 007B21A;
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Hypertension, Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM 4/10/2023 HTN (HYPERTENSION) ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 4/10/2023 HTN (HYPERTENSION)
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Moderna 3/15/21 lot# 031L20A;  Moderna 4/19/21 lot# 040B21A;  Moderna 11/15/21 lot# 039F21A
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Diarrhoea, Dizziness, Dizziness postural, Hypotension
Clinical narrative: I had the vaccine at 3:30pm, and 12 hours later at 3:30am, I woke up with muscle cramps all over my body, chills, and probably a fever. Then shortly thereafter, the vomiting and diareeha started, and then I was very dizzy with dizziness. Then at some point, I was dizzy enough that I took my blood pressure and it was very low, it was 89/62. The vomiting and diareeha lasted for 24 hours. I ate some crackers and ginger ale with lots of water though. Blood pressure stayed low for probably 5 days, it got better each day, then normalized 5-6 days after vaccine. I still get dizzy when I bend low, and it's going on 6 weeks. I only spoke with my doctor, no visits.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Muscle spasms, Pyrexia, Vomiting
Clinical narrative: I had the vaccine at 3:30pm, and 12 hours later at 3:30am, I woke up with muscle cramps all over my body, chills, and probably a fever. Then shortly thereafter, the vomiting and diareeha started, and then I was very dizzy with dizziness. Then at some point, I was dizzy enough that I took my blood pressure and it was very low, it was 89/62. The vomiting and diareeha lasted for 24 hours. I ate some crackers and ginger ale with lots of water though. Blood pressure stayed low for probably 5 days, it got better each day, then normalized 5-6 days after vaccine. I still get dizzy when I bend low, and it's going on 6 weeks. I only spoke with my doctor, no visits.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Hypoxia, Myocardial ischaemia, Respiratory failure, Symptom recurrence
Clinical narrative: DEMAND ISCHEMIA CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 11/5/2022 &  11/26/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ammonia, Blood thyroid stimulating hormone, Death, Metabolic function test
Clinical narrative: Resident expired 5/28/2023
Age: 51.0
Sex: F
Vaccine: FLU4, HEP
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: L. deltoid influenza vaccine administered to employee on 3/23/23. no bleeding noted after administration. She denies redness, swelling, or bruising post administration. She reports "I started having pain about two days after I received the flu vaccine to my L arm right below where the needle was inserted. It is tender when I push on it and it's specifically more sore in the morning when I wake up. I especially notice it when I try to take off a shirt I can't hardly raise my arm up I have to use my Right arm to take my shirt off. I rate my pain 5/10 in the morning and 2/10 throughout the day." Issue lasted 2.5 months and has since resolved.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris, Arteriosclerosis coronary artery, Muscle spasms, Prinzmetal angina
Clinical narrative: PRINZMETAL ANGINA 4/21/2023 ASHD NATIVE COR ART W/ANGINA PECTORIS DOC SPASM
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 16.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Bivalent Covid vaccine administered to patient 8 weeks after 'beyond use date' and therefor dose is not valid. Patient did not have any adverse reactions after vaccine administration.
Age: 91.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccinator inadvertently took a vial from stock with a BUD (10 weeks refrigerated) of 5/29/2023. The vials had not yet been quarantined or disposed of.  Patient has had no known adverse effects. Report is simply due to the use of stock that had passed the BUD by 2 days. Department of Health Services has been contacted for guidance, and we are waiting for a response.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: CRYPTOGENIC STROKE
Age: 7.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Bivalent Covid vaccine administered to patient 8 weeks after 'beyond use date' and therefor dose is not valid. Patient did not have any adverse reactions after vaccine administration.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Central sleep apnoea syndrome, Pneumonia
Clinical narrative: ACUTE RESPIRATORY FAILURE 4/23/2023 PNEUMONIA IDIOPATHIC CENTRAL SLEEP APNEA 4/24/2023 PNEUMONIA
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 11/21/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 5.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient was given kinrix however was not due for DTap or Polio. Patient exhibited no adverse reaction. Patient will be monitored.
Age: 76.0
Sex: F
Vaccine: UNK
Symptoms: Chills, Feeling cold, Pyrexia
Clinical narrative: The Night of the vaccination the patient reported feeling very cold had the chills. The following day the patient developed a 102 degree fever
Age: 25.0
Sex: F
Vaccine: COVID19-2, HEP, HPV9, MMR, TDAP
Symptoms: Cold sweat, Dysphagia, Dyspnoea, Hyperhidrosis, Hypoaesthesia
Clinical narrative: At approximately 09:05 am, the Patient, as mentioned above, reported to the RN she was having a reaction to the vaccines she had received. The Patient received Pfizer Covid-19 Bivalent, Tdap by GSK, Hepatitis B by Dynavax, MMR by MERK, and Gardasil-9 by MERK. Pt reports feeling SOB, and mild difficulty when swallowing, numbness to arm, and nausea. Vitals were immediately taken B/P 79/40 P: 59Pulse Ox: 100% R 20 T: 97.4  9:08 am Upon assessment from NP, patient was noted diaphoretic, cold and clammy. No Generalized urticaria, angioedema, or wheezing was noted on auscultation. A second set of vitals were taken B/P: 70/54 P: 68 Pulse Ox: 100% R 21, T 98. Patient leg elevated. Pt continues having mild difficulty when swallowing. Benadryl 50mg/ml 1ml IM given to Left Deltoid. No acute distress noted at this time.  9:17 am Patient continues in observation. No acute distress was noted.  9:25 am Patient continues in observation. Vital retaken B/P: 106/70 P: 68 Pulse Ox: 100% R18 T: 98.2. No acute distress noted.  9:45am Patient continues in observation. Vital retaken B/P 116/73 P 71 pulse Ox: 100% R 18 T97.7. Pt reports feeling better, no longer feeling SOB, nausea, or numbness. Pt is stable condition no acute distress noted. 10:03 am Vital retaken B/P: 116/72 P: 70 Pulse Ox: 100% R 15 T: 98.0. Pt discharged at this time with discharge instructions and referral to PCP. Pt advised to seek immediate medical attention (emergency services) should she present with any Urticaria, SOB, Chest pain, Angioedema, or difficulty swallowing. Pt verbalized understanding of all discharge instructions given. Pt left in stable condition, accompanied by family member.
Age: 25.0
Sex: F
Vaccine: COVID19-2, HEP, HPV9, MMR, TDAP
Symptoms: Nausea
Clinical narrative: At approximately 09:05 am, the Patient, as mentioned above, reported to the RN she was having a reaction to the vaccines she had received. The Patient received Pfizer Covid-19 Bivalent, Tdap by GSK, Hepatitis B by Dynavax, MMR by MERK, and Gardasil-9 by MERK. Pt reports feeling SOB, and mild difficulty when swallowing, numbness to arm, and nausea. Vitals were immediately taken B/P 79/40 P: 59Pulse Ox: 100% R 20 T: 97.4  9:08 am Upon assessment from NP, patient was noted diaphoretic, cold and clammy. No Generalized urticaria, angioedema, or wheezing was noted on auscultation. A second set of vitals were taken B/P: 70/54 P: 68 Pulse Ox: 100% R 21, T 98. Patient leg elevated. Pt continues having mild difficulty when swallowing. Benadryl 50mg/ml 1ml IM given to Left Deltoid. No acute distress noted at this time.  9:17 am Patient continues in observation. No acute distress was noted.  9:25 am Patient continues in observation. Vital retaken B/P: 106/70 P: 68 Pulse Ox: 100% R18 T: 98.2. No acute distress noted.  9:45am Patient continues in observation. Vital retaken B/P 116/73 P 71 pulse Ox: 100% R 18 T97.7. Pt reports feeling better, no longer feeling SOB, nausea, or numbness. Pt is stable condition no acute distress noted. 10:03 am Vital retaken B/P: 116/72 P: 70 Pulse Ox: 100% R 15 T: 98.0. Pt discharged at this time with discharge instructions and referral to PCP. Pt advised to seek immediate medical attention (emergency services) should she present with any Urticaria, SOB, Chest pain, Angioedema, or difficulty swallowing. Pt verbalized understanding of all discharge instructions given. Pt left in stable condition, accompanied by family member.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: I had a bilateral pulmonary embolism. Treatment was hospitalization for six days full recovery with no complications.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: On 6/1/2023,The vaccinator inadvertently took a vial of vaccine with a BUD (10 weeks refrigerated) of 5/29/2023. No ill effects known to date. The report is being submitted simply as a result of the vaccine being given 2 days after its BUD.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Bivalent Covid vaccine administered to patient 8 weeks after 'beyond use date' and therefor dose is not valid. Patient did not have any adverse reactions after vaccine administration.
Age: 66.0
Sex: F
Vaccine: UNK
Symptoms: Arthralgia, Joint noise, Joint swelling, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Stiffness in hands and fingers.  Swollen painful joint that pops in right thumb.
Age: 66.0
Sex: F
Vaccine: UNK
Symptoms: Peripheral swelling
Clinical narrative: Stiffness in hands and fingers.  Swollen painful joint that pops in right thumb.
Age: 58.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Injection site erythema, Injection site swelling
Clinical narrative: Pt reported redness and swelling of entire right upper arm beginning approximately 1-2 hours post administration.  Pt reports experiencing chills approximately 24 hours post injection.  Reported temperature of 98.8F 24 hours post injection.  Denies all symptoms of anaphylaxis.
Age: 23.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Bivalent Covid vaccine administered to patient 8 weeks after 'beyond use date' and therefor dose is not valid. Patient did not have any adverse reactions after vaccine administration.
Age: 1.25
Sex: M
Vaccine: DTAP
Symptoms: Expired product administered
Clinical narrative: 15 month old came in for his 15 month shots. He was given an expired Dtap it expired on 6/10/23 and pt visit was 6/14/23
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Monovalent mRNA vaccine administered for a bivalent mRNA dose.   Had not been notified (as of date of this vaccine  administration)  that monovalent vaccine had been discontinued). Notice wasn't released until 05-01-2023, sent via e-mail to my supervisor, and then forwarded to me on 05-03-2023 at which time, then all remaining doses of monovalent mRNA vaccine was destroyed.  This patient had no adverse effects or event as result of this dose of vaccine given.  Had already received earlier dose of Pfizer mRNA vaccine. Patient was given Pfizer Bivalent Vaccine Lot GJ 3270, on 06/07/2023 and tolerated well.
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Bivalent Covid vaccine administered to patient 8 weeks after 'beyond use date' and therefor dose is not valid. Patient did not have any adverse reactions after vaccine administration.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Decreased appetite, Dyspnoea, Fatigue, Headache
Clinical narrative: Cold hands & feet. Dry cough. Runny nose. Fever/chills. SEVERE muscle aches. Slight headache. Slight nausea. Severe fatigue the next day. No appetite. Felt like I could not take a deep breath. Heart felt like it was racing. Slept most of the day on Wednesday. Wednesday by late afternoon severe symptoms gone. Thursday morning woke up with severe thigh muscle pain (front and back). Had to take 2 Advil. This reaction was so awful, I will not take another booster.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypersomnia, Myalgia, Nausea, Pain in extremity, Palpitations
Clinical narrative: Cold hands & feet. Dry cough. Runny nose. Fever/chills. SEVERE muscle aches. Slight headache. Slight nausea. Severe fatigue the next day. No appetite. Felt like I could not take a deep breath. Heart felt like it was racing. Slept most of the day on Wednesday. Wednesday by late afternoon severe symptoms gone. Thursday morning woke up with severe thigh muscle pain (front and back). Had to take 2 Advil. This reaction was so awful, I will not take another booster.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Peripheral coldness, Pyrexia, Rhinorrhoea
Clinical narrative: Cold hands & feet. Dry cough. Runny nose. Fever/chills. SEVERE muscle aches. Slight headache. Slight nausea. Severe fatigue the next day. No appetite. Felt like I could not take a deep breath. Heart felt like it was racing. Slept most of the day on Wednesday. Wednesday by late afternoon severe symptoms gone. Thursday morning woke up with severe thigh muscle pain (front and back). Had to take 2 Advil. This reaction was so awful, I will not take another booster.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Angioedema
Clinical narrative: ANGIOEDEMA, INIT
Age: 3.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Bivalent Covid vaccine administered to patient 8 weeks after 'beyond use date' and therefor dose is not valid. Patient did not have any adverse reactions after vaccine administration.
Age: 18.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Diarrhoea, Exposure to extreme temperature, Injection site erythema, Muscle spasms, Occupational exposure to sunlight
Clinical narrative: Pts. Mother calls me and pt. apparently started having some diarrhea yesterday 48 hours after vaccine.  Stated he became crampy in morning. stated his right forearm hurt and his right vaccine site was sore. Pt received the Menn A in his right arm on 6/12/23.  Pt last night had low grade fever 100.5 generalized body aches and vomited a few times and had loose stools.  States he did eat raw hot dog the day before as well , but others did also and did not get ill.  Today he still has no fever, feeling a little better still a little worse stools. I offered a visit today for evaluation. Mother wanted to wait another day. I told her pt. should be seen today if he has a fever, does not continue to improve, if the site with redness does not continue to improve.  We discussed the importance of hydration .  We discussed that with it being more than 24 hours after vaccine may not be vaccine related but the fact he had two vaccines could have potentiated a bug he picked up. Pt works outside in sun all day at the park and recreation so perhaps this work in heat could have potentiated a more intense response.   Mother verbalized understanding.
Age: 18.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Pain, Pain in extremity, Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: Pts. Mother calls me and pt. apparently started having some diarrhea yesterday 48 hours after vaccine.  Stated he became crampy in morning. stated his right forearm hurt and his right vaccine site was sore. Pt received the Menn A in his right arm on 6/12/23.  Pt last night had low grade fever 100.5 generalized body aches and vomited a few times and had loose stools.  States he did eat raw hot dog the day before as well , but others did also and did not get ill.  Today he still has no fever, feeling a little better still a little worse stools. I offered a visit today for evaluation. Mother wanted to wait another day. I told her pt. should be seen today if he has a fever, does not continue to improve, if the site with redness does not continue to improve.  We discussed the importance of hydration .  We discussed that with it being more than 24 hours after vaccine may not be vaccine related but the fact he had two vaccines could have potentiated a bug he picked up. Pt works outside in sun all day at the park and recreation so perhaps this work in heat could have potentiated a more intense response.   Mother verbalized understanding.
Age: 58.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Injection site erythema, Injection site inflammation, Injection site warmth, Pain
Clinical narrative: Redness and inflammation that spread down from injection site along the left bicep.  Patient stated it was warm and her body ached. She is taking tylenol and ibuprofen and using a cold compress.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Speech disorder, Transient ischaemic attack, Visual impairment
Clinical narrative: I did not have an adverse reaction to the vaccine. On 10/29/2022, I went to the emergency room with vision issues in my left eye, dizziness, trouble speaking and talking. I was diagnosed as having a TIA (transient ischaemic attack).  I was referred to a neurologist. As of today, I am doing well.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Coagulopathy
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Nausea, Pallor, Productive cough, Vomiting
Clinical narrative: Patient left clinic with mother and sister after they all got vaccines. Patient began to get nauseous, turned pale, vomited phlegm. Provider had the patient lay down in clinic, mother brought her a lemonade. She drank the lemonade and continued to lay down. Within minutes she got her color back and felt better.